MedCram cover image

Episode 81. Current COVID Risk Assessment: BA.2.86 Variant, Boosters, and More

MedCram

00:00

BA 2.86 variant: Risk assessment and impact on immunity

This chapter explores the BA 2.86 variant of COVID-19, discussing its risk assessment, genetic differences, and impact on immunity. It clarifies confusion regarding its infection capability in individuals with previous COVID-19 infection or vaccination. The chapter also examines the mutations present in the variant and the effectiveness of monoclonal antibodies against it.

Transcript
Play full episode

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
App store bannerPlay store banner